At the Asia-Pacific Biofilms 2026 conference held in Melbourne from 27 to 29 March 2026, Tope A. Ibisanmi delivered an insightful presentation during the multidisciplinary session, focusing on the development of novel peptidomimetics against multidrug-resistant bacteria.
In his talk, Ibisanmi demonstrated the integration of computational design, chemical synthesis, and biological evaluation as a comprehensive approach for accelerating antimicrobial drug discovery. The presentation highlighted how in silico approaches can effectively guide drug development, reducing both time and cost while enhancing precision in identifying candidates with strong antibacterial activity.
Biological evaluation confirmed the potency of the lead compound against clinically relevant strains such as Staphylococcus aureus, MRSA, Escherichia coli, and Acinetobacter baumannii, including significant bactericidal activity and biofilm inhibition.
This research lays the foundation for future work in the development of next-generation antimicrobials. Ibisanmi's work was acknowledged for its multidisciplinary approach, offering promising strategies to tackle the growing threat of multidrug-resistant bacterial infections.
This project would not have been possible without the guidance and support of his supervisor, and he is grateful for the opportunity to work with such a renowned mentor. He also thanks all the organisers and volunteers for their tireless efforts in making the conference possible.
In addition, Tope had the chance to meet several renowned professors and connect with fellow bright students during the program, leading to many engaging and inspiring conversations with the potential to foster future collaborations.